Tumor Necrosis Factor-α in Heart Failure: an Updated Review

Curr Cardiol Rep. 2018 Sep 26;20(11):117. doi: 10.1007/s11886-018-1067-7.

Abstract

Purpose of the review: Proinflammatory cytokines are consistently elevated in congestive heart failure. In the current review, we provide an overview on the current understanding of how tumor necrosis factor-α (TNFα), a key proinflammatory cytokine, potentiates heart failure by overwhelming the anti-inflammatory responses disrupting the homeostasis.

Recent findings: Studies have shown co-relationship between severity of heart failure and levels of the proinflammatory cytokine TNFα and one of its secondary mediators interleukin-6 (IL-6), suggesting their potential as biomarkers. Recent efforts have focused on understanding the mechanisms of how proinflammatory cytokines contribute towards cardiac dysfunction and failure. In addition, how unchecked proinflammatory cytokines and their cross-talk with sympathetic system overrides the anti-inflammatory response underlying failure. The review offers insights on how TNFα and IL-6 contribute to cardiac dysfunction and failure. Furthermore, this provides a forum to begin the discussion on the cross-talk between sympathetic drive and proinflammatory cytokines and its determinant role in deleterious outcomes.

Keywords: Beta-adrenergic receptor; Cardiac hypertrophy and dilation; G-protein coupled receptor kinases; Heart failure; Interleukins; Tumor necrosis factor alpha.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Disease Models, Animal
  • Heart Failure / metabolism*
  • Heart Failure / pathology
  • Humans
  • Interleukin-6 / metabolism*
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Biomarkers
  • Interleukin-6
  • Tumor Necrosis Factor-alpha